These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of 2-substituted oestrogens in vivo on the metabolism of noradrenaline in rat brain.
    Author: Köster G, Breuer H, Schneider HT.
    Journal: Acta Endocrinol (Copenh); 1982 Jan; 99(1):1-8. PubMed ID: 7058671.
    Abstract:
    The effects of oestradiol-17 beta, 2-hydroxyoestradiol-17 beta and 2-methoxyoestradiol-17 beta on the metabolism of [3H]noradrenaline were studied in various brain regions of ovariectomized in rats in vivo. Under the experimental conditions chosen, oestradiol-17 beta had no effect on the metabolic pattern of noradrenaline. After pre-treatment of ovariectomized rats with 2-hydroxyoestradiol-17 beta, the formation of methylate metabolites of noradrenaline (normetanephrine and 3-methoxy-4-hydroxyphenylglycol sulphate) was reduced, whereas that of non-methylated products (3,4-dihydroxymandelic acid and 3,4-dihydroxyphenylglycol sulphate) was increased. The inhibition of methylation was most pronounced in posterior hypothalamus and less significant in anterior hypothalamus and thalamus. Pre-treatment with 2-methoxyoestradiol-17 beta yielded inconsistent results. From the findings described here it may be concluded that 2-hydroxyoestradiol-17 beta, as previously shown in vitro, also affects the metabolism of noradrenaline in vivo by directly interacting with the catechol-O-methyltransferase. It is suggested that this metabolic effect may be responsible - at least to some extent - for the inhibitory effect of 2-hydroxyoestradiol-17 beta on LH secretion.
    [Abstract] [Full Text] [Related] [New Search]